Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05820451 · ClinicalTrials.gov registry record
Impella Real-World Surveillance of Patients Using Sodium Bicarbonate
A clinical trial, sponsored by Abiomed.
- Completed
- Registry status
- 312
- Enrollment target
NCT05820451 is a clinical trial that has completed, run by Abiomed. The registered enrollment target is 312 participants.
The verdict
NCT05820451 has completed, sponsored by Abiomed.
- COMPLETED
- Registry status
- 312 participants
- Enrollment target
Study Summary
The population enrolled in this study are all subjects who received an Impella in which a bicarbonate-based purge solution was used.
Interventions
- DEVICE Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution
- DEVICE Impella RP with Sodium Bicarbonate used as purge solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2022-12-15 |
| Est. Completion | 2024-02-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05820451
The ClinicalTrials.gov registry entry for NCT05820451 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abiomed, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution is the first listed.
NCT05820451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05820451 about?
NCT05820451 is a clinical study titled "Impella Real-World Surveillance of Patients Using Sodium Bicarbonate". The population enrolled in this study are all subjects who received an Impella in which a bicarbonate-based purge solution was used.
What is the current status of trial NCT05820451?
This trial is currently completed. The enrollment target is 312 participants. The study started on 2022-12-15. Estimated completion is 2024-02-22.
What interventions are being tested in trial NCT05820451?
The interventions under investigation include: Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution (DEVICE), Impella RP with Sodium Bicarbonate used as purge solution (DEVICE).
Who is sponsoring clinical trial NCT05820451?
This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.